Relationship between socioeconomic status and metabolic syndrome among Nigerian adults

Adedoyin, Rufus Adesoji; Afolabi, Abiodun; Adegoke, Olajire O.; Akintomide, Anthony Olubunmi; Awotidebe, Taofeek Oluwole

doi:10.1016/j.dsx.2013.02.014

Cited by 28 publications

(31 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of MS in this study is similar to what was found by Oladapo et al (2.4%) 16 in a rural community in south-western Nigeria using the ATP criteria. It is also similar to the findings of Adediran et al 19 (3.7%) in a rural community of Northern Nigeria using the ATP criteria. A higher prevalence of 7.7% was however found using the IDF criteria in their study.…”

Section: Prevalence Of Metabolic Syndromesupporting

confidence: 80%

“…Nigerian studies have estimated the point prevalence of MS to be between 2.4% -26.4%, with a higher rate among women in the general populace. [15][16][17][18][19] The prevalence was also higher in the urban compared to the rural areas. 17,[18][19][20] Among patients with type 2 diabetes, prevalence of MS ranged between 59.1%-87.1%, [21][22][23][24] while in patients with hypertension, the prevalence ranged between 24.7%-40.74%.…”

Section: Introductionmentioning

confidence: 95%

“…[15][16][17][18][19] The prevalence was also higher in the urban compared to the rural areas. 17,[18][19][20] Among patients with type 2 diabetes, prevalence of MS ranged between 59.1%-87.1%, [21][22][23][24] while in patients with hypertension, the prevalence ranged between 24.7%-40.74%. [17][18][19][20][21][22][23][24][25] These Nigerian authors used the WHO, IDF, and Adult Treatment Panel (ATP-III) criteria in their studies.…”

Section: Introductionmentioning

confidence: 99%

“…17,[18][19][20] Among patients with type 2 diabetes, prevalence of MS ranged between 59.1%-87.1%, [21][22][23][24] while in patients with hypertension, the prevalence ranged between 24.7%-40.74%. [17][18][19][20][21][22][23][24][25] These Nigerian authors used the WHO, IDF, and Adult Treatment Panel (ATP-III) criteria in their studies. Prevalence rates for MS in Ghana, 26 Cameroon, 27 South Africa, 28 India, 29 America, 30,31 United Kingdom 32 and Europe 33 ranged between 0% to 49.2% depending on the population studied and the criteria used.…”

Section: Introductionmentioning

confidence: 99%

“…Generally, the prevalence was higher among women than men, 15-19-23-26 and with the IDF definition. [18][19][20][21][22][23][24][25][26] In order to make comparison among various studies possible, a new criterion which harmonizes the previous definitions was proposed. 34 However, there is scanty report on the prevalence of MS with the harmonized criteria Nigeria.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Metabolic Syndrome among Apparently Healthy Nigerians with the Harmonized Criteria: Prevalence and Concordance with the International Diabetes Federation (IDF) and Third Report of the National Cholesterol Education Programme - Adult Treatment Panel III (NCEP-ATP III) Criteria

Raimi¹,

Odusan²,

Fasanmade³

et al. 2017

JCDR

View full text Add to dashboard Cite

Background:The prevalence of metabolic syndrome varies by the definition used and the population studied. In order to make comparison among various studies possible, a new criterion which harmonizes the previous definitions was proposed. This study aims to determine the prevalence of metabolic syndrome with the harmonized criteria, and its concordance with the International Diabetes Federation (IDF), and National Cholesterol Education Programme-Adult Treatment Panel (NCEP-ATP III) criteria. Methods: One hundred and two apparently healthy individuals who participated in health screening were evaluated for metabolic syndrome. The blood pressure and anthropometric parameters were measured according to standard protocol, and fasting plasma glucose and lipid profile were determined. Metabolic syndrome was defined using the Harmonized, IDF and ATP III criteria. The agreement among the three diagnostic criteria was determined with kappa statistics. Results: The prevalence of metabolic syndrome was 4.9%, 3.9% and 4.9% with harmonized, IDF, and NCEP-ATP criteria respectively. Compared to the males, the prevalence was greater in females: Males vs Females (harmonized, 2.2% vs 7.0%; IDF, 2.2% vs 5.3%; NCEP-ATP III, 2.2% vs 7.0%). The commonest risk factor in this population was low HDL occurring in 93.0% and 37.8% of females and males respectively, followed by central obesity (50.9% in females, 13.3% in males with harmonized and IDF criteria; 33.3% in females, 4.4% in males with NCEP-ATP criteria), hypertension (12.5% in females, 18.6% in males) and hyperglycaemia (4.2% in females, 0.0% in males) in that order. None of the participants had elevated Triglyceride. There was a substantial concordance between the harmonized and the IDF (k=0.884) as well as the harmonized and NCEP-ATP III (k=1.000) definitions. Conclusion: The prevalence of metabolic syndrome was low in this population. There was a substantial agreement among the three diagnostic criteria.

show abstract

Section: Prevalence Of Metabolic Syndromesupporting

confidence: 80%